Vivo Bio Tech Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	72.83	25.26	26.49	22.02	56.82
Depreciation & Amortization	69.3	71.98	71.68	59.32	46.9
Other Amortization	20.86	20.93	20.97	15.14	9.02
Loss (Gain) From Sale of Assets	-46.15	-	-	-	-
Other Operating Activities	54.68	62.53	62.84	28.11	-
Change in Accounts Receivable	52.33	-154.26	-61.55	12.51	15.33
Change in Accounts Payable	-105.57	128.78	27.9	29.32	13.69
Operating Cash Flow	118.28	155.22	148.34	166.42	141.76
Operating Cash Flow Growth	-23.80%	4.64%	-10.87%	17.40%	64.69%
Capital Expenditures	-222.7	-79.5	-39.98	-511.12	-228.22
Sale of Property, Plant & Equipment	64.29	-	-	-	-
Investing Cash Flow	-158.42	-79.5	-39.98	-511.12	-228.22
Long-Term Debt Issued	-	-	-	354.29	49.62
Long-Term Debt Repaid	-68.5	-13.04	-69.87	-	-
Net Debt Issued (Repaid)	-68.5	-13.04	-69.87	354.29	49.62
Issuance of Common Stock	89.51	-	27.86	31.37	38.21
Other Financing Activities	18.04	-62.53	-69.74	-35.48	-
Financing Cash Flow	39.05	-75.57	-111.75	350.18	87.83
Miscellaneous Cash Flow Adjustments	-	-	-	0	-
Net Cash Flow	-1.09	0.15	-3.39	5.48	1.37
Free Cash Flow	-104.42	75.72	108.36	-344.7	-86.46
Free Cash Flow Growth	-	-30.12%	-	-	-
Free Cash Flow Margin	-22.37%	16.66%	20.75%	-67.07%	-16.70%
Free Cash Flow Per Share	-6.83	4.54	7.31	-24.34	-6.38
Cash Interest Paid	75.04	77.78	76.51	39.93	35.3
Cash Income Tax Paid	15.1	15.34	19.72	22.71	29.37
Levered Free Cash Flow	-34.6	-105.99	18.8	-390.38	-122.77
Unlevered Free Cash Flow	12.3	-57.37	66.62	-365.42	-100.71
Change in Working Capital	-53.24	-25.48	-33.65	41.83	29.02

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.